SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001347178-21-000009
Filing Date
2021-04-22
Accepted
2021-04-22 07:03:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 27669
2 vandanotice2021page11.jpg GRAPHIC 490600
3 vandanotice2021page21.jpg GRAPHIC 217701
  Complete submission text file 0001347178-21-000009.txt   1003473
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34186 | Film No.: 21843237
SIC: 2834 Pharmaceutical Preparations